Reply to 'Comment on: management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines'
Ann Oncol
.
2013 Apr;24(4):1129-30.
doi: 10.1093/annonc/mdt024.
Epub 2013 Feb 13.
Authors
J A Pérez-Fidalgo
1
,
A Cervantes
Affiliation
1
Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain.
PMID:
23406727
DOI:
10.1093/annonc/mdt024
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Agents / adverse effects*
Extravasation of Diagnostic and Therapeutic Materials / prevention & control*
Humans
Neoplasms / drug therapy*
Substances
Antineoplastic Agents